Company research / MDXR
Medical Exercise Inc. (MDXR)
Beyond the statements
Follow the company.
Explore new filings, reported insider transactions and company relationships.
Annual financials
| Period ended | TTM to 2026-06-30 | 2026-03-31 | 2025-03-31 | 2024-03-31 |
|---|---|---|---|---|
| Revenue | n/a | n/a | $1.3K | n/a |
| Cost of Revenue | n/a | n/a | $445 | n/a |
| Gross Profit | n/a | n/a | $849 | n/a |
| Operating Income | -$204.8K | -$222.4K | -$331.4K | n/a |
| Depreciation & Amortization | $6.4K | $8.7K | $11.5K | n/a |
| EBITDA | -$198.4K | -$213.6K | -$319.9K | n/a |
| Net Income | -$209.1K | -$226.7K | -$331.0K | n/a |
| EPS (Diluted) | n/a | -$0.02 | -$0.03 | n/a |
| Total Assets | $16.7K | $61.3K | $65.3K | $84.7K |
| Shareholders' Equity | -$236.2K | -$183.5K | -$67.3K | -$52.3K |
| Cash & Equivalents | $3.1K | $43.4K | $450 | $10.7K |
| Operating Cash Flow | -$162.9K | -$194.8K | -$191.0K | n/a |
| Capital Expenditures | n/a | n/a | $3.9K | n/a |
| Free Cash Flow | n/a | n/a | -$194.9K | n/a |
| Shares Outstanding | 13.33M | 13.33M | 12.22M | 12.06M |
| Weighted Average Diluted Shares | n/a | 12.60M | 12.19M | n/a |
| EPS (Basic) | n/a | -$0.02 | -$0.03 | n/a |